Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Endometrial Cancer
- Bile Duct Cancer
- Esophageal Cancer
- Gastric Cancer
- Lung Squamous Cell Carcinoma
- Melanoma Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Renal Cell Carcinoma
- Squamous Cell Carcinoma of the Head and Neck
- Urothelial Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04152018
- Collaborators
- Not Provided
- Investigators
- Study Director: Pfizer CT.gov Call Center Pfizer